Patil Neena M 4
4 · Jazz Pharmaceuticals plc · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Jazz Pharmaceuticals EVP Neena Patil Sells 1,200 Shares
What Happened Neena M. Patil, EVP and Chief Legal Officer of Jazz Pharmaceuticals (JAZZ), sold 1,200 ordinary shares on June 10, 2026 at $231.83 per share, generating proceeds of approximately $278,196. The filing reports a sale (S) executed under a pre-established 10b5-1 plan.
Key Details
- Transaction date and price: 2026-06-10 — 1,200 shares sold at $231.83 each.
- Total value: ~$278,196.
- Filing date / timeliness: Form 4 filed 2026-06-12 for the 6/10 trade (filed within the typical 2-business-day reporting window).
- Shares owned after transaction: not specified in the filing.
- Notable footnotes:
- F1: Sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 26, 2026; the trade occurred automatically and was non‑discretionary.
- F2: The reporting person acquired 123 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.
Context This was a routine open-market sale executed under a pre-existing 10b5-1 plan, which typically indicates an automated, pre-planned transaction rather than a discretionary decision about the company’s prospects. Sales do not, by themselves, indicate management’s view of the company.
Insider Transaction Report
Form 4
Patil Neena M
EVP & Chief Legal Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-06-10$231.83/sh−1,200$278,196→ 51,549 total
Footnotes (2)
- [F1]This transaction was made pursuant to a plan adopted by the reporting person on February 26, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.
- [F2]The Reporting Person acquired 123 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.
Signature
By: /s/Paz Dizon, as attorney in fact For: Neena M. Patil|2026-06-12